Mark R. Lilly
@Cm Management, Llc
Latest period2024 - Q3ReportedManaged Assets$125.3MTotal holdings64
Assets growth rate14.98%Assets growth rate (2-Q avg)3.26%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Cm Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 64 positions.
Assets under management
The assets under management (AUM) of Cm Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 125.3M in assets, with a quarterly growth rate of 14.98% and a 2-quarter average growth rate of 3.26%. The portfolio is managed by Mark R. Lilly, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ALCOAlico Inc
| 5.03% | $6.293M 225,000 shares@ $27.97 avg price | |
TGBTaseko Mines Ltd
| 4.93% | $6.174M 2.45M shares@ $2.52 avg price | |
RLGTRadiant Logistics Inc
| 3.98% | $4.983M 775,000 shares@ $6.43 avg price | |
FOLDAmicus Therapeutics Inc
| 3.84% | $4.806M 450,000 shares@ $10.68 avg price | |
RIGLRigel Pharmaceuticals Inc
| 3.75% | $4.692M 290,000 shares@ $16.18 avg price | New Position |
NMRKNewmark Group Inc
| 3.72% | $4.659M 300,000 shares@ $15.53 avg price | Decreased -25% |
RPRXRoyalty Pharma Plc
| 3.62% | $4.526M 160,000 shares@ $28.29 avg price | |
TALOTalos Energy Inc
| 2.9% | $3.623M 350,000 shares@ $10.35 avg price | Increased 75% |
PLPCPreformed Line Prods Co
| 2.76% | $3.458M 27,000 shares@ $128.08 avg price | Increased 3.85% |
CLPTClearpoint Neuro Inc
| 2.69% | $3.363M 300,000 shares@ $11.21 avg price | Decreased -20% |